{
    "Trade/Device Name(s)": [
        "Elecsys PTH Immunoassay",
        "Elecsys PTH STAT Immunoassay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K070709",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992680"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEW"
    ],
    "Summary Letter Date": "July 13, 2007",
    "Summary Letter Received Date": "June 20, 2007",
    "Submission Date": "June 18, 2007",
    "Regulation Number(s)": [
        "21CFR862.1545"
    ],
    "Regulation Name(s)": [
        "Parathyroid hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Parathyroid hormone"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys 1010",
        "Elecsys 2010",
        "MODULAR ANALYTICS E170",
        "cobas e 411",
        "cobas e 601"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys PTH Immunoassay and Elecsys PTH STAT Immunoassay for quantitative measurement of intact parathyroid hormone in serum and plasma.",
    "Indications for Use Summary": "In vitro quantitative determination of intact parathyroid hormone in human serum and plasma for differential diagnosis of hypercalcemia and hypocalcemia, including intraoperative use.",
    "fda_folder": "Clinical Chemistry"
}